journal
MENU ▼
Read by QxMD icon Read
search

P & T: a Peer-reviewed Journal for Formulary Management

journal
https://www.readbyqxmd.com/read/29896037/research-briefs
#1
(no author information available yet)
No abstract text is available yet for this article.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896036/the-international-liver-congress-2018
#2
Walter Alexander
Our coverage of this year's International Liver Congress reviews sessions on hepatitis C, primary biliary cholangitis, nonalcoholic steatohepatitis, homozygous familial hypercholesterolemia, and advanced hepatocellular carcinoma.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896035/targeting-remission-in-moderate-to-severe-crohn-s-disease
#3
Troy Kish
Therapeutic options in development for the treatment of Crohn's disease represent a broad range of approaches to this complex disease. This active pipeline contains a combination of both small-molecule entities and targeted monoclonal antibodies.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896034/comparative-review-of-oral-p2y-12-inhibitors
#4
Renee Koski, Blake Kennedy
Current practice guidelines recommend dual antiplatelet therapy comprised of aspirin and a purinergic signaling receptor Y12 (P2Y12 ) for patients following acute coronary syndrome. This article compares the efficacy, safety, and other characteristics of the three available oral P2Y12 inhibitors-clopidogrel, prasugrel, and ticagrelor.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896033/big-data-and-pharmacovigilance-data-mining-for-adverse-drug-events-and-interactions
#5
C Lee Ventola
Adverse drug events (ADEs), including drug interactions, have a tremendous impact on patient health and generate substantial health care costs. A "big data" approach to pharmacovigilance involves the identification of drug-ADE associations by data mining various electronic sources, including: adverse event reports, the medical literature, electronic health records, and social media. This approach has been useful in assisting the Food and Drug Administration and other regulatory agencies in monitoring and decision-making regarding drug safety...
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896032/congress-moves-toward-opioid-response-2-0-bills-are-wide-ranging-and-well-intentioned-but-mostly-lightweight
#6
Stephen Barlas
Although some aspects of the opioid epidemic, such as physician overprescribing, have lessened in the past few years, the overdose death rate continues to climb. The author describes the latest federal actions aimed at tackling the crisis.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896031/valbenazine-ingrezza-the-first-fda-approved-treatment-for-tardive-dyskinesia
#7
Stepan Uhlyar, Jose A Rey
Valbenazine (Ingrezza): the first FDA-approved treatment for tardive dyskinesia.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896030/pharmaceutical-approval-update
#8
Mary Choy
Burosumab-twza (Crysvita) for a rare inherited form of rickets; ibalizumab-uiyk (Trogarzo) for human immunodeficiency virus type 1 infection; and tildrakizumab-asmn (Ilumya) for adults with moderate-to-severe plaque psoriasis.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896029/drug-and-device-news
#9
(no author information available yet)
Approvals, new indications, regulatory activities, and more.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896028/fda-to-collect-patient-experience-data-upcoming-guidance-documents-will-spell-out-what-and-how-to-submit
#10
Stephen Barlas
FDA to collect patient experience data.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29896027/accidental-overdoses-involving-fluorouracil-infusions
#11
Matthew Grissinger
Accidental overdoses involving fluorouracil infusions.
June 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719373/research-briefs
#12
(no author information available yet)
No abstract text is available yet for this article.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719372/american-college-of-cardiology
#13
Walter Alexander
Key sessions reported on findings in noncardiac surgery, pharmacological agents in the setting of acute coronary syndromes, and cardiotoxicity of cancer therapy.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719371/p-t-committee-drug-prioritization-criteria-a-tool-developed-by-a-saudi-health-care-system
#14
Laila Carolina Abu Esba, Hind Almodaimegh, Ali Alhammad, Mazen Ferwana, Consuela Yousef, Sherine Ismail
Introduction: The workflow of a P&T committee can become overwhelming and may be affected by many internal and external factors. Organization, standardization, and an enhanced systematic approach for drug evaluations are necessary to ensure that all requested drugs receive an equal and unbiased evaluation and consideration for addition based on the institution's objectives, priorities, and budget. Our aim was to create a scoring tool that would assist in systematically prioritizing drugs being requested for formulary addition and to eliminate cumbersome evaluations for drugs that clearly do not offer any additional advantage...
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719370/evaluation-of-physician-prescribing-patterns-for-antibiotics-in-the-treatment-of-nonnecrotizing-skin-and-soft-tissue-infections
#15
Michael C Ezebuenyi, Fatima Brakta, Ifeanyichukwu O Onor, Daniel F Sarpong, Kendrea Bryant-Burks, Julio E Figueroa
Purpose: Skin and soft tissue infections (SSTIs) cause about 15 million cases of infection that result in more than 869,000 annual hospitalizations in the United States. Cellulitis accounted for 63% of all patients hospitalized with SSTIs between 2009 and 2011. The primary objective of this study was to evaluate physician adherence rates to evidence-based practice guidelines. Secondary objectives included evaluating antibiotic selection preferences and duration of therapy. The goal of the project was to generate data to inform the development of a hospital-based protocol for nonnecrotizing SSTI treatment...
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719369/sterile-compounding-needs-risk-management-access-reconstitution-or-preparation-and-administration
#16
Dawn G Holcombe, Rita Marcoux, F Randy Vogenberg
Appropriate risk management strategies must be employed for compounding and administering sterile products. We review the new credentialing, regulatory, and related legal aspects of gaining and maintaining compliance for these processes.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719368/pharmacotherapy-of-gaucher-disease-current-and-future-options
#17
Lunawati L Bennett, Chris Fellner
The clinical manifestations of Gaucher disease, a rare genetic lysosomal storage disorder, are debilitating, and the neuronopathic forms of the disease are fatal. The authors describe the current and investigational therapies for treatment.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719367/compounding-law-five-years-later-fda-implementation-slow-industry-criticism-significant
#18
Stephen Barlas
The FDA is making progress but is still laboring to address safety concerns about compounded drugs, an issue taken up by the Drug Quality and Security Act in 2013.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719366/olaratumab-lartruvo-an-innovative-treatment-for-soft-tissue-sarcoma
#19
Lindsey Penniman, Sapna Parmar, Khilna Patel
Olaratumab (Lartruvo): an innovative treatment for soft tissue sarcoma.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
https://www.readbyqxmd.com/read/29719365/pharmaceutical-approval-update
#20
Mary Choy
Vancomycin hydrochloride for oral solution (Firvanq) for C. difficile -associated diarrhea and enterocolitis caused by S. aureus ; dexamethasone intraocular suspension 9% (Dexycu) for the treatment of inflammation after eye surgery; and apalutamide (Erleada) for prostate cancer.
May 2018: P & T: a Peer-reviewed Journal for Formulary Management
journal
journal
30579
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"